title: Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery.
abstract: Despite the growing number of cancer cases and cancer surgeries around the world, the pharmacokinetics (PK) and pharmacodynamics (PD) of anesthetics used in this population are poorly understood. Patients operated due to cancer are usually in severe state and often require chemotherapy. It might affect the PK/PD of drugs used in this population. Therefore, in this study we explored the PK/PD of propofol in cancer patients having a major lung surgery. 23 patients that underwent a propofol-fentanyl total intravenous anesthesia were included in the analysis. A large set of demographic, biochemical and hemodynamic parameters was collected for the purpose of covariate analysis. Nonlinear mixed effect modeling in NONMEM was used to analyze the collected data. A three-compartment model was sufficient to describe PK of propofol. The anesthetic effect (AAI index) was linked to the propofol effect site concentrations through a sigmoidal E max model. A slightly higher value of clearance, a lower value of distribution clearance, and a decreased volume of peripheral compartment were observed in our patients, as compared with the literature values reported for healthy volunteers by Schnider et al. and by Eleveld et al. Despite these differences, both models led to a clinically insignificant bias of -8 and -1 % in concentration predictions, as reflected by the median performance error. The C e50 and propofol biophase concentration at the time of postoperative orientation were low and equaled 1.40 and 1.13 mg/L. The population PK/PD model was proposed for cancer patients undergoing a major lung surgery. The large body of studied covariates did not affect PK/PD of propofol significantly. The modification of propofol dosage in the group of patients under study is not necessary when TCI-guided administration of propofol by means of the Schnider model is used.
authors: Department of Clinical Pharmacy and Biopharmacy, Karol Marcinkowski University of Medical Sciences, Poznan, Poland.
authors: Krzysztof
authors: K
authors: Przybyłowski
authors: Joanna
authors: J
authors: Tyczka
authors: Damian
authors: D
authors: Szczesny
authors: Agnieszka
authors: A
authors: Bienert
authors: Paweł
authors: P
authors: Wiczling
authors: Katarzyna
authors: K
authors: Kut
authors: Emilia
authors: E
authors: Plenzler
authors: Roman
authors: R
authors: Kaliszan
authors: Edmund
authors: E
authors: Grześkowiak
mesh_terms: D000368:Aged; D018686:Anesthetics, Intravenous / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods; D007700:Kinetics; D008168:Lung / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000601:surgery*; D017711:Nonlinear Dynamics; D015742:Propofol / Q000008:administration & dosage* / Q000493:pharmacokinetics*
chemical_list: D018686:Anesthetics, Intravenous; D005283:Fentanyl; D015742:Propofol
references: Anesthesiology. 1989 Aug;71(2):260-77
references: 2667401
references: Arzneimittelforschung. 2011;61(10):545-52
references: 22164962
references: Anesth Prog. 2001 Spring;48(2):66-71
references: 11515950
references: Anesthesiology. 1998 May;88(5):1170-82
references: 9605675
references: J Clin Anesth. 2002 May;14(3):161-8
references: 12031745
references: Anesthesiology. 2005 Sep;103(3):500-7
references: 16129974
references: Anesthesiology. 1999 Jun;90(6):1571-6
references: 10360854
references: Anesth Analg. 2013 Nov;117(5):1257-9
references: 24149503
references: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 May;87(5):530-8
references: 10348508
references: J Chromatogr. 1987 Oct 9;421(1):171-6
references: 3501430
references: Biomed Chromatogr. 2000 Jun;14(4):249-55
references: 10861736
references: Clin Pharmacokinet. 2012 Aug;51(8):543-551
references: 28258392
references: Anesth Analg. 1995 Oct;81(4):855-61
references: 7574023
references: Clin Pharmacol Ther. 2008 Mar;83(3):443-51
references: 17687274
references: Comput Methods Programs Biomed. 1999 Apr;59(1):19-29
references: 10215174
references: J Clin Anesth. 2003 Mar;15(2):103-7
references: 12719048
references: Br J Anaesth. 2003 Sep;91(3):336-40
references: 12925470
references: Anesthesiology. 2000 Mar;92(3):727-38
references: 10719952
references: Biomed Chromatogr. 2003 Oct;17(7):447-52
references: 14598328
references: Pharmacol Rep. 2012;64(1):113-22
references: 22580527
references: Anesth Analg. 2005 Jan;100(1):4-10
references: 15616043
references: Acta Anaesthesiol Belg. 2001;52(4):445-51
references: 11799580
references: J Pharmacokinet Pharmacodyn. 2001 Oct;28(5):481-504
references: 11768292
references: Br J Anaesth. 2014 Mar;112(3):506-13
references: 24285693
references: Anesthesiology. 1990 Aug;73(2):214-7
references: 2382846
references: J Pharmacokinet Pharmacodyn. 2010 Jun;37(3):243-55
references: 20414709
references: Chin Med J (Engl). 2012 Apr;125(8):1389-92
references: 22613640
references: Anesth Analg. 2014 Jun;118(6):1221-37
references: 24722258
references: Clin Pharmacol Ther. 2004 Apr;75(4):324-30
references: 15060510
references: AAPS J. 2011 Jun;13(2):143-51
references: 21302010
references: Clin Pharmacokinet. 2011 Nov 1;50(11):739-50
references: 21973271
references: AAPS J. 2009 Sep;11(3):558-69
references: 19649712
references: Br J Anaesth. 2010 Aug;105(2):106-15
references: 20627881
references: Br J Clin Pharmacol. 1999 Jan;47(1):35-42
references: 10073737
references: Pharmacol Rep. 2012;64(4):782-95
references: 23087131
references: Br J Anaesth. 2009 Jul;103(1):26-37
references: 19520702
references: Anesth Analg. 2010 Aug;111(2):368-79
references: 19861357
references: CNS Drugs. 2007;21(2):165-71
references: 17284097
references: J Clin Anesth. 1993 Nov-Dec;5(6 Suppl 1):14S-21S
references: 8292364